The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index; 7 of the 9 sources its claims cite were checked for support.
Study protocol for a pilot randomised controlled trial of a virtually delivered behavioural intervention (ACTION) for adults with cancer at risk for opioid use disorder
Open accessAbstract
Introduction Opioid therapy is often central to pain management during cancer care. However, opioid exposure and unaddressed psychological suffering jointly amplify opioid use disorder risk. Therefore, we iteratively developed a behavioural, individually delivered intervention to mitigate the risk of opioid use disorder during cancer care (Acceptance and Commitment Therapy Intervention when Opioids are Necessary (ACTION)). Methods and analysis This is a single-site, non-blinded, randomised, controlled pilot trial of ACTION compared with a waitlist control group. The aims of this study are to examine the feasibility (defined as an overall enrolment rate of ≥60% and a retention rate of >75%) and acceptability (assessed via patient-reported feedback in exit interviews and Client Satisfaction Questionnaire-8 ratings) of ACTION (primary outcomes) and to assess changes in participant-reported depression, anxiety and opioid misuse (secondary outcomes). Patients will be recruited from Dana-Farber Cancer Institute (Boston, Massachusetts, USA). The total number of patients completing the study will be 40. All patients will complete baseline and follow-up measures after 6 weeks. Patients randomly assigned to ACTION (n=20) will receive six weekly 30-min sessions delivered by a mental health provider either via telehealth or in-person. Patients assigned to the waitlist control group (n=20) will be offered the intervention on completion of their follow-up assessments, approximately 6 weeks (±2 weeks), following baseline. Ethics and dissemination This study is approved by the Dana-Farber/Harvard Cancer Center Institutional Review Board (Protocol #21-587). Participants provide either written or electronic informed consent on study approach and once enrolled, they can withdraw from the study at any time. Results will be published in peer-reviewed journals and presented at scientific meetings. Trial registration number NCT05643027. © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.
Overview
CoChat Summary
TL;DR
This paper is a protocol for a single-site, non-blinded pilot randomized controlled trial of ACTION, a virtual behavioral intervention for adults with cancer at risk for opioid use disorder. The trial will compare ACTION with a waitlist control in 40 patients, with the main goals of testing feasibility and acceptability and collecting preliminary changes in depression, anxiety, and opioid misuse.
Key findings
- The study’s primary feasibility targets are an overall enrolment rate of ≥60% and a retention rate of >75%; acceptability will be assessed with exit interviews and Client Satisfaction Questionnaire-8 (CSQ-8) ratings.
- The planned sample is 40 patients, randomized 1:1 to ACTION (n=20) or waitlist control (n=20); as of 21 October 2024, 5 participants had enrolled (2 treatment, 3 control).
- The intervention consists of six weekly 30-minute sessions, delivered by a mental health provider via telehealth or in person, plus a workbook; follow-up assessments occur at 6 weeks (±2 weeks).
- The authors report this is the first manualised behavioural intervention targeting opioid use disorder risk during cancer care, and that it uses Acceptance and Commitment Therapy to address depression, anxiety, coping, and related risk factors.
Methods
- Single-site, non-blinded, randomized, controlled pilot feasibility trial at Dana-Farber Cancer Institute in Boston.
- Eligible participants are adults ≥18 years with any cancer diagnosis, on opioid therapy, at risk for opioid use disorder (Opioid Risk Tool score ≥4), English-speaking enough for psychotherapy, and with estimated survival ≥6 months; patients with cognitive impairment, untreated psychosis, bipolar disorder, or borderline personality disorder are excluded.
- Primary analysis is descriptive/feasibility-focused: enrolment and retention, acceptability (CSQ-8 and interviews), and estimation of effect sizes for secondary outcomes (depression PHQ-9, anxiety GAD-7, opioid misuse COMM), with pilot-oriented analyses rather than inferential hypothesis testing.
Limitations
- The paper states the study is limited to patients receiving care at a Boston-area academic cancer centre, which limits generalisability.
- The paper states that requiring access to videoconferencing-capable devices may bias the sample toward individuals with higher incomes and education.
- The paper states the trial is not blinded and is underpowered for secondary outcomes; additionally, it notes survey noncompletion may indicate that the assessment battery is too long for a future full-scale trial.
- Evident from the protocol: results are not yet available because this is a study protocol for an ongoing trial, not a completed outcome study.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
7 Valid · 0 Not valid · 1 Not checked · 13 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Patients with cancer often rely on opioids to target cancer-related pain.1”
§ Study protocol for a pilot randomised controlled trial of a virtually delivered behavioural intervention (ACTION) for adults with cancer at risk for opioid use disorder > Introduction
What the sources say
- Supportedcites [1] Mudumbai, 2024, Opioid use in cancer patients compared with noncancer pain patients in a veteran population, JNCI Cancer Spectr source
The Discussion states that cancer patients often rely on opioids for severe pain management. The Results also report that 69.0% of cancer patients in the studied veteran population received an opioid prescription. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Of note, survey length was directly assessed in the feasibility phase of this study.15”
§ Study protocol for a pilot randomised controlled trial of a virtually delivered behavioural intervention (ACTION) for adults with cancer at risk for opioid use disorder > Discussion There are several limitations to the current trial. First, the study is limited to patients currently receiving care at a Boston area academic cancer centre, limiting the generalisability of the results. Second, patients who have access to devices (eg, smartphones, computers, tablets) with videoconferencing capability are more likely to participate, which may bias the sample to individuals with higher incomes and education. However, videoconference delivery does have the potential to increase accessibility for patients for whom in-person sessions may be prohibitive due to travel, associated costs and disease-related impediments (eg, pain, fatigue, etc). As observed in our feasibility trial, participants reported a preference for a virtual delivery option.15 Third, although we are using a randomised, controlled design, both the participants and the study therapists are aware of each patient’s study group assignment after randomisation, as it is not possible to conduct a blinded psychosocial intervention study. Finally, although the study is underpowered to examine group differences in secondary outcomes (as this is a universal limitation at this stage of treatment development), the purpose of including all study questionnaires is also to examine the feasibility of participants completing an assessment battery of this size. If participants do not complete the surveys, this may indicate an unacceptable length that would prohibit data collection and analysis in a future full-scale efficacy trial. Of note, survey length was directly assessed in the feasibility phase of this study.15 Despite these limitations, this is the first manualised behavioural intervention to target opioid use disorder during cancer care, using an existing, evidence-based therapeutic approach (Acceptance and Commitment Therapy). All enrolled participants can receive the intervention, as those randomised to the waitlist control group are offered the intervention following completion of follow-up measures. This intervention also has clinical training opportunities embedded within it, which may enhance its scalability in future iterations, including a larger efficacy trial.
What the sources say
- Partly supportedcites [15] Yusufov, 2023, An acceptance and commitment therapy-based intervention for opioid use disorder risk in individuals with cancer: A treatment development study, J Contextual Behav Sci sourceExperimental — accuracy not yet measured
The Method > Patient Feedback and Results > Feasiblity Results passages say the study assessed feasibility through completion of pre- and post-intervention questionnaires. They do not report directly assessing survey length or the time needed to complete the questionnaires (no page numbers provided). (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“reported that the intervention fostered accountability and normalised internal experiences (eg, feelings, thoughts, memories)”
§ Study protocol for a pilot randomised controlled trial of a virtually delivered behavioural intervention (ACTION) for adults with cancer at risk for opioid use disorder > Introduction
What the sources say
- Supportedcites [15] Yusufov, 2023, An acceptance and commitment therapy-based intervention for opioid use disorder risk in individuals with cancer: A treatment development study, J Contextual Behav Sci source
The Results (Exit Interview Results, Themes 3 and 4) report that participants felt held accountable between sessions and that the intervention normalized internal experiences, including feelings, thoughts, and memories. The Method (Patient Feedback) identifies these accounts as feedback collected in exit interviews during the feasibility-focused study. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“For example, a study of 751 patients with cancer suggested that those with an anxiety disorder had an increased risk for aberrant medication behaviours.7”
§ Study protocol for a pilot randomised controlled trial of a virtually delivered behavioural intervention (ACTION) for adults with cancer at risk for opioid use disorder > Introduction
What the sources say
- Partly supportedcites [7] Yennurajalingam, 2018, Predicting the risk for aberrant opioid use behavior in patients receiving outpatient supportive care consultation at a comprehensive cancer center, Cancer sourceExperimental — accuracy not yet measured
The Results report 751 new consultations, of which 729 were evaluable, and an association between higher ESAS anxiety scores and screening positive for risk of aberrant opioid use. The Methods describe ESAS anxiety as a symptom-severity measure, not a diagnosis of anxiety disorder; the study assessed risk rather than observed medication behaviours. No page numbers are available in our copy. (LLM, conf=0.88)
hedgedstates an associationn = 751- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Participants also preferred virtual delivery, particularly because it was convenient and lowered barriers to research participation.15”
§ Study protocol for a pilot randomised controlled trial of a virtually delivered behavioural intervention (ACTION) for adults with cancer at risk for opioid use disorder > Introduction
What the sources say
- Supportedcites [15] Yusufov, 2023, An acceptance and commitment therapy-based intervention for opioid use disorder risk in individuals with cancer: A treatment development study, J Contextual Behav Sci source
The Discussion (page not provided) says participants found remote delivery increased their willingness to participate and lowered barriers to study completion. Lessons Learned adds that remote visits maximized flexibility. Together, these support the citing sentence’s paraphrase of why participants favored remote delivery. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
7 more claims · 2 with their cited sources checked
Create a free account to see all 21 claims and every source verdict.
- Probably not a substantial claim. 5
- It may state two separate claims as one. 5
Citations
Cites
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384
A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765
Statistical Power Analysis for the Behavioral Sciences
Cohen, J. (2013) · doi:10.4324/9780203771587 · Cited by 25,373
You want to measure coping but your protocol’ too long: Consider the brief cope
Carver, C. S. (1997) · International Journal of Behavioral Medicine · doi:10.1207/s15327558ijbm0401_6 · Cited by 7,361
The PHQ-8 as a measure of current depression in the general population
Kroenke, K., Strine, T. W., Spitzer, R. L., Williams, J. B. W., Berry, J. T., & Mokdad, A. H. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.06.026 · Cited by 5,121
Bond, F. W., Hayes, S. C., Baer, R. A., Carpenter, K. M., Guenole, N., Orcutt, H. K., Waltz, T., & Zettle, R. D. (2011) · Behavior Therapy · doi:10.1016/j.beth.2011.03.007 · Cited by 3,950
Anxiety, sensitivity, anxiety frequency, and the prediction of fearfulness
Reiss, S., Peterson, R. A., Gursky, D. M., & McNally, R. J. (1986) · Behaviour Research and Therapy · doi:10.1016/0005-7967(86)90143-9 · Cited by 3,169
The role and interpretation of pilot studies in clinical research
Leon, A. C., Davis, L. L., & Kraemer, H. C. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.10.008 · Cited by 1,917
The client satisfaction questionnaire
Attkisson, C. C., & Zwick, R. (1982) · Evaluation and Program Planning · doi:10.1016/0149-7189(82)90074-x · Cited by 1,743
Webster, L. R., & Webster, R. M. (2005) · Pain Medicine · doi:10.1111/j.1526-4637.2005.00072.x · Cited by 1,096
Cited by
Idrees, Y., Alqaisi, O., Al‐Ghabeesh, S. H., Stublla, M., Sijarina, L., Souied, O., Joseph, K., & Tai, P. (2026) · Exploration of Medicine · doi:10.37349/emed.2026.1001388 · Cited by 2
Metadata
- Authors
- Yusufov, M., Pirl, W. F., Greer, J. A., Mazzola, E., Dalrymple, K. L., Tulsky, J. A., Braun, I. M., & McHugh, R. K.
- Affiliations
- Harvard University (US)
- Brown University (US)
- Corresponding author
- Yusufov, Miryam
- ORCID
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2024-12
- Volume
- 14
- Issue
- 12
- Pages
- e096546
- ISSN
- 2044-6055 (ISSN-L)
- PMC
- PMC11624744
- OpenAlex
- W4405128019
- Semantic Scholar
- 3f633732da609623081fa5deef54f3a281eca04d
- Cited by
- 1
- References
- 31
- Citations by year
- 2026: 1
- FWCI
- 0.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMJ Open (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (acceptedVersion)
- Funders
- National Cancer Institute (K08 CA 259538; PI: Yusufov)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- opioid use disorder, cancer pain management, acceptance and commitment therapy, behavioral interventions, depression, anxiety, opioid misuse, feasibility and acceptability
- MeSH terms
- Cancer Pain, Adult, Analgesics, Opioid, Behavior Therapy, Feasibility Studies, Female, Humans, Male, Opioid-Related Disorders, Neoplasms, Pilot Projects, Randomized Controlled Trials as Topic, Pain Management, Acceptance and Commitment Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Study protocol for a pilot randomised controlled trial of a virtually delivered behavioural intervention (ACTION) for adults with cancer at risk for opioid use disorder. https://app.cochat.ai/papers/10.1136/bmjopen-2024-096546
- The paper
- Yusufov, M., Pirl, W. F., Greer, J. A., Mazzola, E., Dalrymple, K. L., Tulsky, J. A., Braun, I. M., & McHugh, R. K. (2024). Study protocol for a pilot randomised controlled trial of a virtually delivered behavioural intervention (ACTION) for adults with cancer at risk for opioid use disorder. BMJ Open. https://doi.org/10.1136/bmjopen-2024-096546
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
